Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05271617 · ClinicalTrials.gov registry record
VIDAS Nephroclear (NCL) CCL14 - Sample Stability
A clinical trial, sponsored by BioMérieux.
- Completed
- Registry status
- 40
- Enrollment target
NCT05271617 is a clinical trial that has completed, run by BioMérieux. The registered enrollment target is 40 participants.
The verdict
NCT05271617 has completed, sponsored by BioMérieux.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This VIDAS® NEPHROCLEAR™ CCL14 (VIDAS® NCL™ CCL14) Sample Stability clinical trial is a multicenter, prospective, and qualitative study. The main study objective is to determine sample stability conditions for the VIDAS® NEPHROCLEAR™ CCL14 Test. This test is intended to be used in conjunction with clinical evaluation in ICU patients with moderate to severe (stage 2 or 3) acute kidney injury (AKI) as an aid in the risk assessment for developing persistent severe AKI (stage 3 AKI lasting ≥ 72 hours) within 48 hours of patient assessment. The VIDAS® NEPHROCLEAR™ CCL14 Test is intended to be used in patients 21 years of age or older.
Interventions
- DIAGNOSTIC_TEST VIDAS® NEPHROCLEAR™ CCL14
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-03-10 |
| Est. Completion | 2023-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05271617
The ClinicalTrials.gov registry entry for NCT05271617 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BioMérieux, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VIDAS® NEPHROCLEAR™ CCL14 is the first listed.
NCT05271617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05271617 about?
NCT05271617 is a clinical study titled "VIDAS Nephroclear (NCL) CCL14 - Sample Stability". This VIDAS® NEPHROCLEAR™ CCL14 (VIDAS® NCL™ CCL14) Sample Stability clinical trial is a multicenter, prospective, and qualitative study. The main study objective is to determine sample stability conditions for the VIDAS® NEPHROCLEAR™ CCL14 Test. This test is intended to be used in conjunction with c...
What is the current status of trial NCT05271617?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2022-03-10. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT05271617?
The interventions under investigation include: VIDAS® NEPHROCLEAR™ CCL14 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05271617?
This trial is sponsored by BioMérieux, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.